Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Sun Pharma's PrILUMYA™ now available to help Canadians living with moderate-tosevere plaque psoriasis

Posted On: 2021-10-28 15:12:04 (Time Zone: IST)


Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceuticals Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" including its subsidiaries and/or associate companies) is pleased to announce PrILUMYA™ (tildrakizumab injection), a treatment for adults living with moderateto-severe plaque psoriasis, is now available in Canada.

"We are excited to introduce this important biologic treatment to Canadians living with this common, inhibiting and often-overlooked disease. This launch is an important milestone for Sun Pharma, as we expand our dermatology portfolio into Canada," said Abhay Gandhi, CEO North America, Sun Pharma. "With five years of effective treatment of moderate-to-severe plaque psoriasis, ILUMYA demonstrates our commitment to providing innovative medicines to support patient lifestyle and physician choice."

Plaque psoriasis is a chronic autoimmune disease that appears on the skin as red, raised areas of the skin covered with flaky white scales that can crack and bleed. It affects approximately 850,000 Canadians. Moderate-to-severe plaque psoriasis affects about 35% of patients. A key challenge is that many treatments stop working overtime and symptoms return. Durability of treatment in the long-term is an unmet need for many patients.

"Moderate-to-severe plaque psoriasis can make it difficult to feel comfortable in your own skin and the search for an effective treatment can be as challenging as the disease itself," said Dr. Melinda Gooderham, a board-certified Dermatologist and Medical Director at the SKiN Centre for Dermatology in Peterborough, Ontario. "Our patients need options for an effective, durable and continuous treatment in Canada and ILUMYA will help meet that need."

In a published peer reviewed journal of the pooled analyses of the two trials reSURFACE 1 and reSURFACE 2, the data shows that most patients on ILUMYA maintained response and a reassuring safety profile through 5 years of treatment.

In patients who were treated with ILUMYA 100 mg, nearly nine out of 10 maintained their response through Year 5. ILUMYA 100 mg was well-tolerated during the Phase 3 trials. The three adverse reactions that occurred more frequently than placebo and ?1% in clinical trials were upper respiratory infections (15.1% vs. 12.3%), injection site reactions (3.9% vs. 2.6%) and headache (3.2% vs. 2.9%).

In Canada, some patients involved in the study have reported still having clear skin eight years later.

"I have patients who have been treated with ILUMYA for the past eight years, and I have seen their skin improve to high levels of clearance, and stay clear for the long term. As a result, their lives have also improved," added Dr. Gooderham.

"All my life I struggled with moderate-to-severe plaque psoriasis, and I constantly rotated between creams and ointments that never worked and only added to my stress. Until I learned about ILUMYA, I thought I had run out of treatment options," said Ainsley Leween, psoriasis patient. "Since I started using ILUMYA eight years ago, my psoriasis has been under control."

Canadian Agency for Drugs and Technologies in Health (CADTH), through the Common Drug Review, has positively recommended to the provinces it deals with that the ILUMYA product be reimbursed for patients with moderate-to-severe plaque psoriasis, when prescribed by a dermatologist.

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 825.35 as compared to the previous close of Rs. 813.55. The total number of shares traded during the day was 180521 in over 5109 trades.

The stock hit an intraday high of Rs. 838.40 and intraday low of 814.00. The net turnover during the day was Rs. 150230520.00.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Dynacons to set up IT infrastructure for State Bank of India for their New Branch Channel Project

IndusInd Bank launches NRI Homecoming festival to celebrate Indian diaspora returning home

Lupin partners with TTP plc UK for Soft-mist Inhalation Technology Platform

RattanIndia's Revolt Motors opens its first Dealership store in Kolkata

Optiemus Electronics Limited wins Industry Award

Shipnext ceases to be subsidiary of Eastern Treads Ltd

Sh. Amitabh Kant, CEO, NITI Aayog launches Genesys International's digital twin platform

NDTV Convergence's Exclusive 10-Year, 750-Crore Deal with Taboola

Aegis Logistics Limited to transfer liquid storage units at Haldia Dock Complex

Hero MotoCorp announces sales volume for November 2021

Capital Trust Limited announces Expansion in Branch Network

RITES Ltd updates on orders received from Railways

NXTDIGITAL Limited's rights issue subscribed by 1.94 times, receives Rs. 560.13 crores

S Chand launches 'Learnflix Bangla' focused on West Bengal Market

Satin Creditcare Network Ltd board to consider fund raising on Dec 6, 2021

Axita Cotton Ltd receives new order from Bangladesh

The Dharamsi Morarji Chemical Company Limited lists on NSE

Marathon Nextgen Realty Ltd approves debt issue for Rs. 450 crore

Perfect-Octave Media Projects Ltd receives renewal permission for Insync

The Federal Bank Limited's credit ratings reaffirmed

Globus Spirits Ltd gets order to supply 9.68 crores litres of Ethanol to OMCs

Raymond Ltd announces OFS of JK Files & Engineering Ltd

TT Ltd board declares interim dividend of Rs. 1

Infosys and Proximus Extend Collaboration on IT Application Transformation and Development

LOGOS and Mahindra Logistics developing 1.4million sf of Multi-Client BTS Warehouses in Delhi-NCR

Khaitan Chemicals and Fertilizers Ltd wins award

IndiGrid wins its first greenfield transmission project

eSense learning Pvt Ltd to invest in SFA Sporting Services Pvt Ltd

Coastal Corporation Ltd arm conducts groundbreaking ceremony for ethanol project

Shri Rakesh Kumar Jain joins as Director (Finance), GAIL

Parag Milk Foods Limited updates on IT search

HFCL expands global business, appoints two industry leaders to further strengthen worldwide presence

JMC Projects India Ltd secures new orders of Rs. 1,795 Crores

S Chand to acquire minority stake in AI/Data Sciences focussed Ed Tech Startup - iNeuron Intelligence

Mahindra's Farm Equipment Sector Sells 26094 Units in India during November 2021

Cigniti Technologies supports Belagavi Institute of Medical Sciences (BIMS) Karnataka with medical equipment

Escorts Construction Equipment sold 312 machines in November 2021

Decipher Labs Ltd opens branch office in Indore

Hatsun Agro Product Ltd inaugurates Ice Cream Plant at Govindapur, Telangana

Maruti Suzuki posts sales of 139184 units in November 2021

India's largest Solar and Battery Storage Project awarded to Tata Power Solar of INR 945 crore

Ridhi Synthetics Ltd board fixes Dec 10, 2021 as record date for rights issue

Mindtree has Earned the AI and Machine Learning on Microsoft Azure Advanced Specialization

WardWizard sells more than 3,290 units of electric two-wheelers in November 2021

Biocon Enters Prestigious Dow Jones Sustainability Emerging Markets Index

Sapphire Foods opens 500th store and expects to double store base in next 3-4 years

Infosys InStep Ranked as the 'Best Internship Program' for Four Consecutive Years

Inauguration of GRSE KPDD Unit, Kolkata

Ashoka Metcast Limited allots 30,12,000 convertible Warrants

Mahindra Auto sells 40102 vehicles in November 2021, Utility Vehicles register a growth of 8%


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020